期刊
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY
卷 15, 期 -, 页码 1991-1995出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/CCID.S373115
关键词
adalimumab; autoinflammatory syndrome; palmoplantar pustulosis; plaque psoriasis; pyoderma gangrenosum
类别
资金
- National Natural Science Foundation of China [82173400, 81972931]
- Medical and Health Science and Technology Project of Health Commission of Zhejiang Province [2020KY558]
Pyoderma gangrenosum (PG) is a rare autoinflammatory skin disorder with challenging treatment. We reported a patient with coexisting PG, plaque psoriasis, and palmoplantar pustulosis (PPP) who recovered after treatment with adalimumab.
Pyoderma gangrenosum (PG) is a rare autoinflammatory skin disorder, which is characterised by rapidly developing and tender cutaneous ulcers. The treatment of PG is challenging. Palmoplantar pustulosis (PPP) is also an autoinflammatory dermatosis with sterile pustules on the palms and/or the soles. We demonstrated a 68-year-old patient with coexisting autoinflammatory diseases including PG, 1-year history of plaque psoriasis and PPP, recovered after treatment with adalimumab. We also reviewed published reports of PG-associated autoinflammatory syndromes with adalimumab.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据